FDA
approval
· 2018-02-01
FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
Summary
FDA approved a supplemental application for ZUBSOLV (buprenorphine and naloxone) from Orexo US, Inc. This action updates the product's labeling per the approved…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZUBSOLV (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)